These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29433148)

  • 1. International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.
    Gosselin RC; Adcock DM; Bates SM; Douxfils J; Favaloro EJ; Gouin-Thibault I; Guillermo C; Kawai Y; Lindhoff-Last E; Kitchen S
    Thromb Haemost; 2018 Mar; 118(3):437-450. PubMed ID: 29433148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.
    Gouveia F; Bicker J; Santos J; Rocha M; Alves G; Falcão A; Fortuna A
    J Pharm Biomed Anal; 2020 Mar; 181():113109. PubMed ID: 31981828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban.
    Platton S; Hunt C
    Int J Lab Hematol; 2019 Apr; 41(2):227-233. PubMed ID: 30468572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A; Chantarangkul V; Legnani C; Testa S; Tosetto A
    J Thromb Haemost; 2018 Mar; 16(3):565-570. PubMed ID: 29322630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.
    Douxfils J; Adcock DM; Bates SM; Favaloro EJ; Gouin-Thibault I; Guillermo C; Kawai Y; Lindhoff-Last E; Kitchen S; Gosselin RC
    Thromb Haemost; 2021 Aug; 121(8):1008-1020. PubMed ID: 33742436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.
    Bonar R; Favaloro EJ; Mohammed S; Ahuja M; Pasalic L; Sioufi J; Marsden K
    Pathology; 2016 Jan; 48(1):60-71. PubMed ID: 27020211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical verification and comparison of chromogenic assays for dabigatran, rivaroxaban and apixaban determination on BCSXP and STA Compact Max analysers.
    Ćelap I; Margetić S; Brčić M; Mihić R
    Biochem Med (Zagreb); 2020 Feb; 30(1):010706. PubMed ID: 32063729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.
    Harenberg J; Du S; Wehling M; Zolfaghari S; Weiss C; Krämer R; Walenga J
    Clin Chem Lab Med; 2016 Feb; 54(2):275-83. PubMed ID: 26167981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?
    Lippi G; Favaloro EJ
    Clin Chem Lab Med; 2015 Feb; 53(2):185-97. PubMed ID: 25241734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
    Gous T; Couchman L; Patel JP; Paradzai C; Arya R; Flanagan RJ
    Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory measurement of the direct oral anticoagulants.
    Dale BJ; Chan NC; Eikelboom JW
    Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Council for Standardization in Haematology (ICSH) recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests.
    Adcock DM; Moore GW; Kershaw GW; Montalvao SAL; Gosselin RC
    Int J Lab Hematol; 2024 Jul; ():. PubMed ID: 39009028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting.
    Gosselin RC; Adcock D; Dorgalaleh A; Favaloro EJ; Lippi G; Pego JM; Regan I; Siguret V
    Semin Thromb Hemost; 2020 Jun; 46(4):398-409. PubMed ID: 31639855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement.
    Wiegele M; Schöchl H; Haushofer A; Ortler M; Leitgeb J; Kwasny O; Beer R; Ay C; Schaden E
    Crit Care; 2019 Feb; 23(1):62. PubMed ID: 30795779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants (DOACs): From the laboratory point of view.
    Margetić S; Goreta SŠ; Ćelap I; Razum M
    Acta Pharm; 2022 Dec; 72(4):459-482. PubMed ID: 36651369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. International Committee for Standardization in Haematology & International Committee on Thrombosis and Haemostasis.
    Scand J Clin Lab Invest; 1985 Nov; 45(7):669-70. PubMed ID: 4070965
    [No Abstract]   [Full Text] [Related]  

  • 20. International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing.
    Kitchen S; Adcock DM; Dauer R; Kristoffersen AH; Lippi G; Mackie I; Marlar RA; Nair S
    Int J Lab Hematol; 2021 Dec; 43(6):1272-1283. PubMed ID: 34581008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.